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Brief report
Autosomal dominant reticuloendothelial iron overload associated with a
3–base pair deletion in the ferroportin 1 gene (SLC11A3)
Vinod Devalia, Kymberley Carter, Ann P. Walker, Stephen J. Perkins, Mark Worwood, Alison May, and James S. Dooley
We describe a family with autosomal
dominant inheritance of increased body
iron stores characterized by raised se-
rum ferritin concentration and normal
transferrin saturation. Liver biopsy
showed iron deposition in Kupffer cells
without fibrosis. The clinical features of
HFE-related hemochromatosis were ab-
sent, as were the Cys282Tyr and
His63Asp mutations. Venesection therapy
was poorly tolerated, suggesting a de-
fect in iron release from reticuloendothe-
lial stores. A 3–base pair deletion in
exon 5 of the ferroportin 1 gene
(SLC11A3) predicting Val162 deletion
was found in affected members, but not
in unaffected individuals or in 100 con-
trol subjects. Consensus structural pre-
dictions of the transmembrane helices
showed that the deletion is in the extra-
cellular loop between the third and
fourth predicted transmembrane heli-
ces and lies within a spatial cluster of
other known ferroportin 1 mutations.
These results indicate that this extracel-
lular cluster is functionally important
for iron transport, and its disruption
leads to iron overload. (Blood. 2002;
100:695-697)
© 2002 by The American Society of Hematology
Introduction
Genetic hemochromatosis is usually an autosomal recessive condi-
tion in which excessive iron absorption causes iron overload,
primarily in parenchymal cells. It is associated with HFE missense
mutations (Cys282Tyr, His63Asp). In the United Kingdom, more
than 90% of cases of genetic hemochromatosis are HFE related.1
We describe a family with autosomal dominant, reticuloendothelial
iron overload due to a mutation in ferroportin 1 (IREG1, MTP1,
official name: solute carrier family 11, member A3, or SLC11A3), a
newly discovered gene encoding a transmembrane protein involved
in iron release from cells.2-4
Study design
Clinical evaluation
The proband (38 years) presented with fatigue. Her serum ferritin concentra-
tion was 2855 g/L (normal range up to 200 g/L) and transferrin
saturation was 40% (normal range up to 50%). There was no intercurrent
disease to explain the high ferritin level, and a liver biopsy revealed heavy
iron deposition in both hepatocytes and Kupffer cells. After 5 venesections
(450 mL blood per week), the hemoglobin dropped to 9.0 g/dL. A bone
marrow aspiration indicated “mild dyserythropoiesis with defective
hemoglobinization.”
The proband’s sister (34 years) had a high serum ferritin concentration
(1150 g/L) and a transferrin saturation of 31%. A magnetic resonance
imaging (MRI) scan suggested iron accumulation in both the liver and
spleen. Liver biopsy showed no fibrosis and marked iron accumulation in
Kupffer cells (Figure 1). Bone marrow aspiration showed “mild dyserythro-
poiesis.” Her hemoglobin concentration fell to 9.9 g/dL after 6 phleboto-
mies. The proband’s father (61 years) had a serum ferritin concentration of
4850 g/L and transferrin saturation of 37%. MRI showed evidence of iron
deposition in the liver and spleen and some hepatic steatosis. He declined
liver biopsy or venesection.
The 2 sisters received erythropoietin (4000 units twice a week) during
phlebotomy to prevent anemia. The proband underwent venesection every 2
weeks for 15 months, and about 6 g Fe was removed. About 8 g Fe was
removed from her sister over 18 months, when the serum ferritin had fallen
to 230 g/L. Erythropoietin was discontinued, but she became anemic and
required further treatment with erythropoietin before the hemoglobin
concentration returned to normal.
Elevated serum ferritin associated with normal transferrin saturation was
found in other family members investigated, consistent with an autosomal
dominant mode of inheritance. Some members of the family initially requested
investigation but did not wish to be included in this paper.
Genetic studies
Genomic DNA isolation5 and Cys282Tyr and His63Asp mutation analysis of
HFE were performed as previously described.1 The genomic structure of the
ferroportin 1 gene was determined from a BLAST search using the cDNA
(AF231121). Eight exons were mapped on the GenBank genomic contig
sequence NT_022197.2. Direct sequencing of the exons and flanking intron–
exon boundaries was carried out using the ABI Prism Terminator Cycle
Sequencing Ready Reaction kit (PE Applied Biosystems, Foster City, CA) and
ABI Prism 377 DNA sequencer. All products were sequenced in both directions
(primers and conditions are available from the corresponding author).
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Transmembrane helix prediction
Hydrophobicity plots were derived from 8 software packages (Figure 2)
for each of the human, rat, mouse, and zebrafish ferroportin 1 sequences.
The consensus of the 9 helix predictions was determined by a majority
vote in all 32 calculations. The helix topology with respect to the
orientation of the lipid bilayer was generally predicted6 by the “positive-
inside rule.” The prediction of transmembrane helices is accurate to
about 96%, and the accuracy of the determination of the transmembrane
helical regions is 3 residues. The expected accuracy of the topology
prediction is greater than 86%, with higher than average accuracies for
eukaryotic proteins.
Results and discussion
In this family, affected members had an elevated serum ferritin
concentration and normal transferrin saturation without the clinical
features of genetic hemochromatosis. Iron was deposited in
Kupffer cells (Figure 1) with no evidence of fibrosis. No family
members carried HFE Cys282Tyr or His63Asp. In the proband’s
sister, normal coding sequence and splice sites were demonstrated
for both HFE and 2-microglobulin.7
Analysis of the ferroportin 1 gene showed 4 changes from the
genomic contig: (1) homozygosity for 8 rather than 7 CGG
trinucleotides8 in the likely promoter region in one affected
family member that was not family specific; (2) a G to C
transversion within the first intron (IVSI-24; dbSNP entry
399162) that did not correlate with increased serum ferritin and
that, in 124 control chromosomes, had a frequency of 0.17; (3) a
T to C transversion at the third base of codon 221, homozygous
in 3 family members and 3 control subjects and identical to the
cDNA sequences AF231121 and AF226614; and (4) a 3–base
pair deletion in exon 5; affected but not unaffected family
members were heterozygous for this deletion. The deletion
(delGTT/TTG/TGT) involves any 3 sequential bases from
c779 to 790 (AF231121) and predicts the loss of 1 of 3 Val
residues 160-162 conserved across several vertebrate spe-
cies.2-4 The deletion was not found in 100 subjects without
iron overload.
This Val162del mutation appears to lead to loss of function
and deficiency in the release of iron from phagocytic cells,
which becomes apparent on venesection. Serum ferritin concen-
trations reflect the increased level of storage iron in reticuloen-
dothelial cells. In contrast, in HFE-related hemochromatosis,
in which iron is initially confined to hepatic parenchymal cells,
the transferrin saturation is elevated and the serum ferritin may
be normal.9
Two other mutations in the human ferroportin 1 gene have been
reported. Njajou et al10 described a Dutch pedigree with a missense
mutation (Asn144His) in exon 5, resulting in autosomal dominant
hemochromatosis with significant iron overload treatable by
phlebotomy. Montosi et al11 reported a missense mutation
(Ala77Asp) in exon 3 of the ferroportin 1 gene in an autosomal
dominant, Italian hemochromatosis pedigree. The transferrin
saturation was elevated in 8 of 15 family members with a raised
serum ferritin concentration. There was a reduced tolerance of
therapeutic venesection in 2 members. Njajou et al10 proposed
that the effect of the Asn144His mutation was a gain of function
causing enhanced iron absorption, but Montosi et al11 suggested
a loss of function and haploinsufficiency resulting from the
mutation Ala77Asp.
The structure shown in Figure 2 has 9 transmembrane helices
with the expected lengths of 18 to 22 residues generally
predicted consistently to within 1 residue. Helix 4 was an
exception and may start as early as Leu183 and finish as late as
Trp219. Two methods predicted that helix 9 may start at Gly490
and be followed by a 10th helix, as previously reported.2,3 The
distribution of 12 Cys residues in human, mouse, and rat
ferroportin 1 within the lipid bilayer and on the 2 surfaces is
consistent with the formation of disulfide bridges between
pairs of Cys residues within each of these regions. Six predic-
tion methods for the helix topology favored the location of
the N-terminus of ferroportin 1 to be within the cell cytoplasm.
This is supported by the location of 3 of the 4 putative
N-glycosylation sites on the external loops of ferroportin 1, as
expected for a membrane protein (the fourth is predicted to be
inside transmembrane 2 and is assumed to be unglycosylated).
The mutations are all located at either the end of the
transmembrane helices 1 and 3 or at the extracellular loop at the
C-terminal end of helix 3. In common with other analyses of
clusters of residue mutations,12,13 this suggests that these define
a functional binding site for a protein, such as apotransferrin,
ceruloplasmin, or hephaestin, that is important for the export of
iron from the cell.14
The treatment of patients with this disorder remains unclear.
Whether iron removal is absolutely necessary is questionable
because the degree of overload was not great and the liver biopsies
did not show organ damage.
This report highlights the importance of ferroportin 1 in
regulating export of iron across the macrophage membrane. A
study of the role of ferroportin 1 in other disorders characterized by
elevated ferritin associated with anemia, namely the anemia of
chronic disorders, may give further insights into the mechanism of
iron release.
Figure 1. Liver histology (Perls stain). Liver biopsy for the proband’s sister showing
iron staining predominantly in Kupffer cells. (A) Low power; (B) high power.
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Figure 2. Sequence analysis and topology of the predicted transmembrane helices in ferroportin 1. The software packages used were: TM pred, TMAP, and DAS via the
PIX program at www.hgmp.mrc.ac.uk/; SOSUI (www.tuat.ac.jp/mitaku/); TopPred2 (bioweb.pasteur.fr/seqanal/interfaces/toppred.html); TMHMM2.0 (www.cbs.dtu.dk/services/
TMHMM-2.0/); HMMTOP2 (www.enzim.hu/hmmtop/); and PHDhtm/PHDtopology (www.embl-heidelberg.de/predictprotein/predictprotein.html). The sequence accession
numbers were: human, NM_014585; mouse, NM_016917; rat, AF394785; and zebrafish, AF226612. In NM_016917, the unspecified amino acid Xaa365 was specified as
Arg365 by comparison with AF215637. (A) The sequence is annotated in order to identify the consensus transmembrane helices predicted from 8 methods and the locations of
the 4 mutations identified to date in human and zebrafish ferroportin 1 (bold and underlined). The zebrafish Leu167Phe mutation is responsible for the hypochromic anemia
weissherbst phenotype.2 Leu167Phe in zebrafish is equivalent to Leu170Phe in the predicted human sequence. The sequence numbering is denoted by a vertical stroke at
every fifth residue and the bracketed number at the end of each line. The locations of the 12 Cys residues (*) and 3 extracellular putative N-linked oligosaccharide sites (#) are in
bold type and underlined (see text). (B) The 9 predicted transmembrane helices (1-9) are shown in relation to the lipid bilayer, with the positions of the 4 mutations (red circles),
12 Cys residues (yellow circles), and 3 putative exposed N-linked oligosaccharide sites (Y) marked as shown. The N- and C-termini are denoted by N and C, respectively. The
residue length of each ferroportin 1 loop is denoted by the numbers adjacent to each one.
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